Delivery Order SPE2DB22D1106-SPE2DB25FFBB1
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) valued at $6,629.15 under a firm fixed-price contract. The award, made on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count) valued at $1,908.93, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,458.52, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the contractor's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (quantity 100s) with a ceiling value of $1,316.65. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitive award with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.27 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,780.22 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 60 mg tablets (100 count) valued at $1,351.82, with a firm fixed price structure and no set-aside designation. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count) valued at $1,640.40, with a firm fixed-price contract type and an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBB1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains extensive contractual relationships with the Defense Logistics Agency's Medical Supply Chain to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract encompasses deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with AmerisourceBergen positioned as one of multiple anticipated prime vendors under the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/1/25 |